Oncolytics Biotech® Receives Fast Track Designation for Pelareorep in Second-Line and Later Anal Cancer
Go back to Oncolytics Biotech® Receives Fast Track Designation for Pelareorep in Second-Line and Later Anal Cancer| Oncolytics Biotech, Inc. (NASDAQ: ONCY) | Delayed: 0.85 +0.02 (2.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.83 | 52 Week High | $1.37 | |||
| Open | $0.81 | 52 Week Low | $0.24 | |||
| Day High | $0.85 | P/E | N/A | |||
| Day Low | $0.81 | EPS | $0.00 | |||
| Volume | 1,067,122 | |||||
